Fig. 9From: Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacyApoptosis assay using flow cytometry following the treatment of cells for 24 h. a Control; b free curcumin + free paclitaxel; c free curcumin; d free paclitaxel; e niosomal curcumin; f niosomal paclitaxel; g niosomal curcumin + niosomal paclitaxelBack to article page